drugset / Trial / NCT03754309
A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this research study is to investigate if KY1005 results in improvement of eczema when given to participants with moderate to severe disease. Side effects of KY1005 will also be explored.
Timeline
- Start
- 2018-12-13
- Primary completion
- 2020-05-12
- Completion
- 2020-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlitelimab | Monoclonal antibody | — | — |